Alken RG - Search Results

1

Kinetics of medroxalol, a beta- and alpha-adrenoceptor antagonist.

Haegele KD, Jaillon P, Cheymol G, Alken RG, Schechter PJ, Koch-Weser J. Haegele KD, et al. Among authors: alken rg. Clin Pharmacol Ther. 1983 Dec;34(6):785-91. doi: 10.1038/clpt.1983.250. Clin Pharmacol Ther. 1983. PMID: 6641094

2

Kinetics of fenoximone, a new cardiotonic, in healthy subjects.

Alken RG, Belz GG, Haegele KD, Meinicke T, Schechter PJ. Alken RG, et al. Clin Pharmacol Ther. 1984 Aug;36(2):209-16. doi: 10.1038/clpt.1984.164. Clin Pharmacol Ther. 1984. PMID: 6235081

3

Kinetics of alpha-difluoromethylornithine: an irreversible inhibitor of ornithine decarboxylase.

Haegele KD, Alken RG, Grove J, Schechter PJ, Koch-Weser J. Haegele KD, et al. Among authors: alken rg. Clin Pharmacol Ther. 1981 Aug;30(2):210-7. doi: 10.1038/clpt.1981.150. Clin Pharmacol Ther. 1981. PMID: 6788425

4

Determination of the R(-)- and S(+)-enantiomers of gamma-vinyl-gamma-aminobutyric acid in human body fluids by gas chromatography--mass spectrometry.

Haegele KD, Schoun J, Alken RG, Huebert ND. Haegele KD, et al. Among authors: alken rg. J Chromatogr. 1983 May 13;274:103-10. doi: 10.1016/s0378-4347(00)84413-8. J Chromatogr. 1983. PMID: 6874815

5

Assay of gamma-vinyl-gamma-aminobutyric acid (4-amino-hex-5-enoic acid) in plasma and urine by automatic amino acid analysis. Application to human pharmacokinetics.

Grove J, Alken RG, Schechter PJ. Grove J, et al. Among authors: alken rg. J Chromatogr. 1984 Mar 9;306:383-7. doi: 10.1016/s0378-4347(00)80903-2. J Chromatogr. 1984. PMID: 6715477 No abstract available.

6

Digoxin concentrations in serum and cantharides blister fluid: correlations with cardiac response.

Schäfer-Korting M, Belz GG, Brauer J, Alken RG, Mutschler E. Schäfer-Korting M, et al. Among authors: alken rg. Clin Pharmacol Ther. 1987 Dec;42(6):613-20. doi: 10.1038/clpt.1987.208. Clin Pharmacol Ther. 1987. PMID: 3690939 Clinical Trial.

7

A comparative dose-effect study with cardiac glycosides assessing cardiac and extracardiac responses in normal subjects.

Alken RG, Belz GG. Alken RG, et al. J Cardiovasc Pharmacol. 1984 Jul-Aug;6(4):634-40. doi: 10.1097/00005344-198407000-00013. J Cardiovasc Pharmacol. 1984. PMID: 6206318 Clinical Trial.

8

Cardiovascular effects, pharmacokinetics and cross-reactivity in digitalis glycoside immunoassays of an antidiarrheal uzara root extract.

Schmiedl S, Ritter A, Szymanski J, Schneider F, Plecko T, Alken RG, Thuermann PA. Schmiedl S, et al. Among authors: alken rg. Int J Clin Pharmacol Ther. 2012 Oct;50(10):729-40. doi: 10.5414/CP201712. Int J Clin Pharmacol Ther. 2012. PMID: 22784612 Clinical Trial.

9

Deuterium-substituted L-DOPA displays increased behavioral potency and dopamine output in an animal model of Parkinson's disease: comparison with the effects produced by L-DOPA and an MAO-B inhibitor.

Malmlöf T, Feltmann K, Konradsson-Geuken Å, Schneider F, Alken RG, Svensson TH, Schilström B. Malmlöf T, et al. Among authors: alken rg. J Neural Transm (Vienna). 2015 Feb;122(2):259-72. doi: 10.1007/s00702-014-1247-6. Epub 2014 Jun 7. J Neural Transm (Vienna). 2015. PMID: 24906468

10

Deuterium substitutions in the L-DOPA molecule improve its anti-akinetic potency without increasing dyskinesias.

Malmlöf T, Rylander D, Alken RG, Schneider F, Svensson TH, Cenci MA, Schilström B. Malmlöf T, et al. Among authors: alken rg. Exp Neurol. 2010 Oct;225(2):408-15. doi: 10.1016/j.expneurol.2010.07.018. Epub 2010 Jul 24. Exp Neurol. 2010. PMID: 20659451

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters